About
CanSinoBIO
688185.SH
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides.
Profile
- Company Name
- CanSino Biologics Inc.
- Market
- SHSE
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- cansinotech.com